Headache, migraine. Migraine
Conditions
Interventions
Intervention 1: Intervention group: The group receiving the standard drug Amirtriptyline along with Migrafar capsules (prepared and provided by Nutek Far Pharmaceutical Company), which receives one or
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 18 Years
Inclusion criteria
Inclusion criteria: Definitive diagnosis of primary headache Mild to moderate headache intensity Age range from 6 to 18 years Absence of secondary cause for headache Not taking any other medicine for headache
Exclusion criteria
Exclusion criteria: Uncertain diagnosis of headache
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The intensity of the headache will be measured by Visual Scale Questionnaire (VAS). Timepoint: At the beginning and three months after taking the medicine, we check the result. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of headaches. Timepoint: At the beginning of the research and three months after receiving the drug. Method of measurement: Number of daily headaches.;Type of headache. Timepoint: At the beginning of the research and three months after receiving the drug. Method of measurement: To be pulsatile or non-pulsatile.;Location of headache. Timepoint: At the beginning of the research and three months after receiving the drug. Method of measurement: Unilateral or bilateral. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Sadeghi
Shahre-kord University of Medical Sciences
Outcome results
None listed